Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Stockholders' Equity

v3.23.1
Consolidated Statements of Stockholders' Equity - USD ($)
$ in Thousands
Total
Private Placement
IPO
Common Stock
Common Stock
Private Placement
Common Stock
IPO
Convertible Preferred Stock
Series F Preferred Stock
Additional Paid-In Capital
Additional Paid-In Capital
Private Placement
Additional Paid-In Capital
IPO
Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2020       8,651,400     21,754,000        
Beginning balance at Dec. 31, 2020 $ (28,102)     $ 9     $ 0 $ 232,530     $ (260,641)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                      
Shares pursuant to private placement, IPO and Exchange Transaction (in shares)         546,733 8,000,000          
Shares pursuant to private placement, IPO and Exchange Transaction   $ 4,072 $ 36,085   $ 1 $ 8     $ 4,071 $ 36,077  
Share-based compensation (in shares)       17,537              
Share-based compensation 4,140             4,140      
Warrant exercises (in shares)       380,716              
Warrant exercises 1,685             1,685      
Shares issued to third-parties for services (in shares)       5,000              
Shares issued to third-parties for services 46             46      
Warrant modifications 0             402     (402)
Conversion of Series F shares to common stock (in shares)       7,251,205     (21,754,000)        
Conversion of Series F shares to common stock 0     $ 7       (7)      
Conversion of convertible notes to common stock (in shares)       4,732,420              
Conversion of convertible notes to common stock 21,776     $ 5       21,771      
Shares issued in lieu of fractional shares due to reverse stock split (in shares)       1,081              
Reclassification of warrant liability to equity $ 16,387             16,387      
Share repurchases (in shares) (439,725)     (439,725)              
Share repurchases $ (1,601)     $ (1)             (1,600)
Net (loss) income 3,387                   3,387
Ending balance (in shares) at Dec. 31, 2021       29,146,367     0        
Ending balance at Dec. 31, 2021 57,875     $ 29     $ 0 317,102     (259,256)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                      
Share-based compensation (in shares)       283,900              
Share-based compensation $ 2,969             2,969      
Share repurchases (in shares) 0                    
Net (loss) income $ (39,316)                   (39,316)
Ending balance (in shares) at Dec. 31, 2022       29,430,267     0        
Ending balance at Dec. 31, 2022 $ 21,528     $ 29     $ 0 $ 320,071     $ (298,572)